Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher'

Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher'

On CNBC’s "Mad Money Lightning Round," Jim Cramer said BioXcel Therapeutics Inc BTAI "may be home run or nothing, and that’s always tough."

When asked about 4D Molecular Therapeutics Inc FDMT, he said, "Regeneron Pharmaceuticals, Inc. REGN is the horse to bet on, because it’s been a great investment."

When asked about SoFi Technologies Inc SOFI, he said, "I do believe it’s bottoming, but I don’t know what gets it higher."

Price Action: Shares of BioXcel Therapeutics gained 1.3% to close at $15.55, while 4D Molecular Therapeutics jumped 6.6% to $22.40 on Thursday. SoFi Technologies shares fell 2.7% to settle at $5.38 in the previous session.

Photo via Shutterstock. 

Posted In: CNBCJim CramerLong IdeasNewsSmall CapTop StoriesMarketsMediaTrading Ideas